Canopy Growth And Technical Communications Corporation On The List Of Winners And Losers Of Wednesday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today‚Äôs list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Canopy Growth, Gevo, and Aurora Cannabis.

Rank Financial Asset Price Change Updated (EST)
1 Canopy Growth (CGC) 9.55 32.09% 2024-03-27 15:24:44
2 Gevo (GEVO) 0.73 19.52% 2024-03-27 14:58:19
3 Aurora Cannabis (ACB) 4.75 12.83% 2024-03-27 15:02:25
4 Tandem Diabetes Care (TNDM) 33.69 11.93% 2024-03-26 23:12:07
5 Nikola (NKLA) 0.91 11.43% 2024-03-27 14:48:04
6 SNDL Inc. (SNDL) 2.18 10.66% 2024-03-27 15:03:45
7 iRobot (IRBT) 8.59 9.85% 2024-03-27 15:14:12
8 Enphase Energy (ENPH) 119.80 9.56% 2024-03-27 15:12:44
9 Energous Corporation (WATT) 1.97 9.47% 2024-03-27 10:42:07
10 Marathon (MARA) 22.07 8.27% 2024-03-27 14:59:24

The three biggest losers today are Technical Communications Corporation, XTL Biopharmaceuticals Ltd., and GameStop.

Rank Financial Asset Price Change Updated (EST)
1 Technical Communications Corporation (TCCO) 0.31 -20.58% 2024-03-26 21:12:08
2 XTL Biopharmaceuticals Ltd. (XTLB) 2.60 -15.31% 2024-03-27 13:43:07
3 GameStop (GME) 13.17 -15.03% 2024-03-27 15:55:23
4 21Vianet Group (VNET) 1.62 -9.72% 2024-03-27 07:43:06
5 Celsius Holdings (CELH) 83.43 -8.54% 2024-03-27 15:02:15
6 DraftKings (DKNG) 45.35 -6.84% 2024-03-27 15:02:27
7 Streamline Health Solutions (STRM) 0.46 -6.11% 2024-03-26 19:11:07
8 Synergetics USA (SURG) 3.86 -5.85% 2024-03-26 19:41:07
9 Translate Bio (TBIO) 0.44 -5.19% 2024-03-26 21:06:08
10 Trinity Biotech plc (TRIB) 2.02 -5.16% 2024-03-26 23:47:08

Winners today

1. Canopy Growth (CGC) – 32.09%

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

NASDAQ ended the session with Canopy Growth rising 32.09% to $9.55 on Wednesday while NASDAQ rose 0.51% to $16,399.52.

Earnings Per Share

As for profitability, Canopy Growth has a trailing twelve months EPS of $-15.65.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -121.56%.

More news about Canopy Growth.

2. Gevo (GEVO) – 19.52%

Gevo, Inc. operates as a carbon abatement company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company focuses on transforming renewable energy into energy-dense liquid hydrocarbons that can be used as renewable fuels. It offers renewable gasoline and diesel, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006. Gevo, Inc. was incorporated in 2005 and is headquartered in Englewood, Colorado.

NASDAQ ended the session with Gevo jumping 19.52% to $0.73 on Wednesday, following the last session’s downward trend. NASDAQ jumped 0.51% to $16,399.52, after two successive sessions in a row of losses, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Gevo has a trailing twelve months EPS of $-0.28.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -11.39%.

Volume

Today’s last reported volume for Gevo is 18536400 which is 187.36% above its average volume of 6450420.

Yearly Top and Bottom Value

Gevo’s stock is valued at $0.73 at 17:32 EST, under its 52-week low of $0.78.

More news about Gevo.

3. Aurora Cannabis (ACB) – 12.83%

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

NYSE ended the session with Aurora Cannabis jumping 12.83% to $4.75 on Wednesday while NYSE jumped 1.09% to $18,255.24.

Earnings Per Share

As for profitability, Aurora Cannabis has a trailing twelve months EPS of $-58.18.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -102.67%.

Yearly Top and Bottom Value

Aurora Cannabis’s stock is valued at $4.75 at 17:32 EST, way above its 52-week high of $1.21.

Volume

Today’s last reported volume for Aurora Cannabis is 9011350 which is 482.82% above its average volume of 1546160.

More news about Aurora Cannabis.

4. Tandem Diabetes Care (TNDM) – 11.93%

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. Its products in development include t:sport insulin delivery system; and connected (mobile) health offerings. Tandem Diabetes Care, Inc. has a development and commercialization agreement with Dexcom, Inc. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

NASDAQ ended the session with Tandem Diabetes Care rising 11.93% to $33.69 on Wednesday while NASDAQ jumped 0.51% to $16,399.52.

Earnings Per Share

As for profitability, Tandem Diabetes Care has a trailing twelve months EPS of $-3.43.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -59.08%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 10.8%, now sitting on 747.72M for the twelve trailing months.

Moving Average

Tandem Diabetes Care’s value is way higher than its 50-day moving average of $26.34 and way higher than its 200-day moving average of $24.96.

Volume

Today’s last reported volume for Tandem Diabetes Care is 2668980 which is 44.62% above its average volume of 1845450.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is a negative 19% and a negative 70%, respectively.

More news about Tandem Diabetes Care.

5. Nikola (NKLA) – 11.43%

Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions in the United States and internationally. The company operates in truck and energy units. It commercializes battery electric vehicles (BEV) and hydrogen fuel cell electric vehicles (FCEV) to the trucking sector. In addition, it develops a network of hydrogen fueling stations; and offers BEV charging solutions for its FCEV and BEV customers, as well as other third-party customers. Further, its products include Nikola Tre Class 8 truck and the Nikola's Class 8 FCEV. Additionally, the company assembles, integrates, and commissions its vehicles in collaboration with its business partners and suppliers. Nikola Corporation founded in 2015 and is headquartered in Phoenix, Arizona.

NASDAQ ended the session with Nikola rising 11.43% to $0.91 on Wednesday while NASDAQ jumped 0.51% to $16,399.52.

Earnings Per Share

As for profitability, Nikola has a trailing twelve months EPS of $-1.21.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -138.82%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Nikola’s EBITDA is 19.95.

Yearly Top and Bottom Value

Nikola’s stock is valued at $0.91 at 17:32 EST, way under its 52-week high of $3.71 and way higher than its 52-week low of $0.52.

Volatility

Nikola’s last week, last month’s, and last quarter’s current intraday variation average was a positive 5.80%, a negative 0.10%, and a positive 3.97%.

Nikola’s highest amplitude of average volatility was 5.80% (last week), 3.64% (last month), and 3.97% (last quarter).

More news about Nikola.

6. SNDL Inc. (SNDL) – 10.66%

SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use and medical markets; sells wines, beers, and spirits through wholly owned liquor stores; and private sale of recreational cannabis through wholly owned and franchised retail cannabis stores. In addition, the company produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.

NASDAQ ended the session with SNDL Inc. rising 10.66% to $2.18 on Wednesday while NASDAQ rose 0.51% to $16,399.52.

Earnings Per Share

As for profitability, SNDL Inc. has a trailing twelve months EPS of $-0.48.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.6%.

More news about SNDL Inc..

7. iRobot (IRBT) – 9.85%

iRobot Corporation designs, builds, and sells robots and home innovation products in the United States, Europe, the Middle East, Africa, Japan, and internationally. The company offers floor care products, including Roomba floor vacuuming robots; Roomba accessories and consumables, such as the Clean Base Automatic Dirt Disposal, replacement dirt disposal bags for the Clean Base, filters, brushes, and batteries; Braava family of automatic floor mopping robots; and Braava accessories and consumables, which include cleaning solution, washable and disposable mopping pads, replacement tanks, and batteries, as well as subscription services. It also provides Root robots for coding, discovery, and play; Roomba Combo mopping and vacuuming robot; and accessories, including robot vacuum and mop, handheld vacuum, and air purifier, educational coding robot, and accessory bundles. The company sells its products through chain stores and other national retailers, value- added distributors, and resellers, as well as through its website and app, and e-commerce websites. iRobot Corporation was incorporated in 1990 and is headquartered in Bedford, Massachusetts.

NASDAQ ended the session with iRobot rising 9.85% to $8.59 on Wednesday, after five sequential sessions in a row of losses. NASDAQ jumped 0.51% to $16,399.52, after two successive sessions in a row of losses, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, iRobot has a trailing twelve months EPS of $-11.01.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4%.

More news about iRobot.

8. Enphase Energy (ENPH) – 9.56%

Enphase Energy, Inc., together with its subsidiaries, designs, develops, manufactures, and sells home energy solutions for the solar photovoltaic industry in the United States and internationally. The company offers semiconductor-based microinverter, which converts energy at the individual solar module level and combines with its proprietary networking and software technologies to provide energy monitoring and control. It also provides microinverter units and related accessories, an IQ gateway; IQ batteries; the cloud-based Enlighten monitoring service; storage solutions; and electric vehicle charging solutions, as well as design, proposal, permitting, and lead generation services. The company sells its solutions to solar distributors; and directly to large installers, original equipment manufacturers, strategic partners, and homeowners, as well as through its legacy product upgrade program or online store. Enphase Energy, Inc. was incorporated in 2006 and is headquartered in Fremont, California.

NASDAQ ended the session with Enphase Energy rising 9.56% to $119.80 on Wednesday while NASDAQ jumped 0.51% to $16,399.52.

Earnings Per Share

As for profitability, Enphase Energy has a trailing twelve months EPS of $3.08.

PE Ratio

Enphase Energy has a trailing twelve months price to earnings ratio of 38.9. Meaning, the purchaser of the share is investing $38.9 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 48.52%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 58.2%, now sitting on 2.29B for the twelve trailing months.

Volume

Today’s last reported volume for Enphase Energy is 4881390 which is 17.47% above its average volume of 4155380.

Previous days news about Enphase Energy

  • Here's why enphase energy (enph) fell more than broader market. According to Zacks on Tuesday, 26 March, "In the latest trading session, Enphase Energy (ENPH Quick QuoteENPH – Free Report) closed at $109.35, marking a -1.53% move from the previous day. ", "Analysts and investors alike will be keeping a close eye on the performance of Enphase Energy in its upcoming earnings disclosure. "

More news about Enphase Energy.

9. Energous Corporation (WATT) – 9.47%

Energous Corporation develops wire-free charging solutions. The company develops WattUp wireless power technology that consists of semiconductor chipsets, software controls, hardware designs, and antennas that enables radio frequency based wire-free charging for electronic devices. It has a strategic partnership with Xentris Wireless to develop ruggedized products for military applications using the company's radio frequency based charging technology. The company's products are used in home, medical, automotive, industrial, military and office. Energous Corporation was formerly known as DvineWave Inc. and changed its name to Energous Corporation in January 2014. The company was founded in 2012 and is headquartered in San Jose, California.

NASDAQ ended the session with Energous Corporation jumping 9.47% to $1.97 on Wednesday while NASDAQ rose 0.51% to $16,399.52.

Earnings Per Share

As for profitability, Energous Corporation has a trailing twelve months EPS of $-4.89.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -94.37%.

Yearly Top and Bottom Value

Energous Corporation’s stock is valued at $1.97 at 17:32 EST, way under its 52-week high of $11.18 and way above its 52-week low of $1.51.

More news about Energous Corporation.

10. Marathon (MARA) – 8.27%

Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines digital assets with a focus on the bitcoin ecosystem in United States. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings, Inc. was incorporated in 2010 and is headquartered in Fort Lauderdale, Florida.

NASDAQ ended the session with Marathon jumping 8.27% to $22.07 on Wednesday, following the last session’s downward trend. NASDAQ rose 0.51% to $16,399.52, after two sequential sessions in a row of losses, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Marathon has a trailing twelve months EPS of $1.06.

PE Ratio

Marathon has a trailing twelve months price to earnings ratio of 20.82. Meaning, the purchaser of the share is investing $20.82 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.09%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Marathon’s stock is considered to be overbought (>=80).

Yearly Top and Bottom Value

Marathon’s stock is valued at $22.07 at 17:32 EST, way under its 52-week high of $34.09 and way higher than its 52-week low of $5.35.

Volume

Today’s last reported volume for Marathon is 56547700 which is 33.27% below its average volume of 84745100.

Previous days news about Marathon

  • Marathon digital holdings, inc. (mara) ascends while market falls: some facts to note. According to Zacks on Monday, 25 March, "Investors might also notice recent changes to analyst estimates for Marathon Digital Holdings, Inc. Recent revisions tend to reflect the latest near-term business trends. ", "In terms of valuation, Marathon Digital Holdings, Inc. is presently being traded at a Forward P/E ratio of 149.07. "
  • Marathon petroleum (mpc) declines more than market: some information for investors. According to Zacks on Tuesday, 26 March, "In terms of valuation, Marathon Petroleum is currently trading at a Forward P/E ratio of 13.61. ", "Analysts and investors alike will be keeping a close eye on the performance of Marathon Petroleum in its upcoming earnings disclosure. "

More news about Marathon.

Losers Today

1. Technical Communications Corporation (TCCO) – -20.58%

Technical Communications Corporation engages in the design, development, manufacture, distribution, marketing, and sale of communications security devices, systems, and services worldwide. The company primarily provides data, video, fax, and voice networks. Its products include government systems, such as CSD 3324 SE secure telephone, fax and data system; CSD 3324 SP telephone and fax system; DSD 72A-SP military bulk ciphering system; and DSP 9000 radio encryption system, as well as the HSE 6000 squad radio headset and telephone encryptor for public safety special operations, land mobile radio applications, and for military applications. The company also provides network security systems comprising network encryption systems with centralized key and device management for IP, SONET/SDH, and frame relay networks to secure data in transit from local area network to local area network and across wide area networks. In addition, it offers secure office systems, such as CSD 4100 executive secure telephone and CipherTalk 8500 Internet protocol (IP)-based secure wireless phone. The company's products are used to protect confidentiality in communications between radios, landline telephones, mobile phones, facsimile machines, data network equipment over wires, fiber optic cables, radio waves, and microwave and satellite links. Further, it offers funded research and development, and technology development services. The company serves various markets, including foreign and domestic governmental agencies, law enforcement and military agencies, telecommunications carriers, financial institutions, and multinational companies requiring protection of mission-critical information. It sells directly to customers, original equipment manufacturers, and value-added resellers using its in-house sales force, as well as domestic and international representatives, consultants, and distributors. Technical Communications Corporation was founded in 1961 and is based in Concord, Massachusetts.

NASDAQ ended the session with Technical Communications Corporation falling 20.58% to $0.31 on Wednesday while NASDAQ rose 0.51% to $16,399.52.

Earnings Per Share

As for profitability, Technical Communications Corporation has a trailing twelve months EPS of $-1.24.

Volume

Today’s last reported volume for Technical Communications Corporation is 100 which is 79.83% below its average volume of 496.

Moving Average

Technical Communications Corporation’s value is way under its 50-day moving average of $0.40 and way under its 200-day moving average of $0.60.

Revenue Growth

Year-on-year quarterly revenue growth declined by 76.1%, now sitting on 353.55k for the twelve trailing months.

Yearly Top and Bottom Value

Technical Communications Corporation’s stock is valued at $0.31 at 17:32 EST, way under its 52-week high of $1.00 and way higher than its 52-week low of $0.24.

More news about Technical Communications Corporation.

2. XTL Biopharmaceuticals Ltd. (XTLB) – -15.31%

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. Its lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. XTL Biopharmaceuticals Ltd. has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel.

NASDAQ ended the session with XTL Biopharmaceuticals Ltd. dropping 15.31% to $2.60 on Wednesday, after five sequential sessions in a row of gains. NASDAQ rose 0.51% to $16,399.52, after two consecutive sessions in a row of losses, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, XTL Biopharmaceuticals Ltd. has a trailing twelve months EPS of $-0.4.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -62%.

More news about XTL Biopharmaceuticals Ltd..

3. GameStop (GME) – -15.03%

GameStop Corp., a specialty retailer, provides games and entertainment products through its stores and ecommerce platforms in the United States, Canada, Australia, and Europe. The company sells new and pre-owned gaming platforms; accessories, such as controllers, gaming headsets, and virtual reality products; new and pre-owned gaming software; and in-game digital currency, digital downloadable content, and full-game downloads. It also sells collectibles comprising apparel, toys, trading cards, gadgets, and other retail products for pop culture and technology enthusiasts, as well as engages in the digital asset wallet and NFT marketplace activities. The company operates stores and ecommerce sites under the GameStop, EB Games, and Micromania brands; and pop culture themed stores that sell collectibles, apparel, gadgets, electronics, toys, and other retail products under the Zing Pop Culture brand, as well as offers Game Informer magazine, a print and digital gaming publication. The company was formerly known as GSC Holdings Corp. GameStop Corp. was founded in 1996 and is headquartered in Grapevine, Texas.

NYSE ended the session with GameStop dropping 15.03% to $13.17 on Wednesday, after two successive sessions in a row of gains. NYSE jumped 1.09% to $18,255.24, after three sequential sessions in a row of losses, on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, GameStop has a trailing twelve months EPS of $-0.02.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.65%.

Previous days news about GameStop

  • Gamestop (gme) Q4 earnings and revenues lag estimates. According to Zacks on Tuesday, 26 March, "While GameStop has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"

More news about GameStop.

4. 21Vianet Group (VNET) – -9.72%

21Vianet Group, Inc., an investment holding company, provides hosting and related services to Internet companies, government entities, blue-chip enterprises, and small-to mid-sized enterprises in the People's Republic of China. It offers hosting and related services to house servers and networking equipment in its data centers, and connects them through a data transmission network. The company's hosting and related services include managed hosting services that offer data center space to house its customers' servers and networking equipment, and provide tailored server administration services; and interconnectivity services that enable customers to connect their servers with internet backbones and other networks through its border gateway protocol network or single-line, dual-line, or multiple-line network. Its hosting and related services also comprise cloud services that enable businesses to run their applications over the internet using its IT infrastructure; virtual private network services; hybrid IT Services, which provide customers with a complete package of infrastructure service offerings; and other value-added services, such as firewall, server load balancing, data backup and recovery, data center management, server management, and backup server services. In addition, the company provides traffic charts and analysis, gateway monitoring for servers, domain name system setup, defense mechanism against distributed denial of service attacks, basic setting of switches and routers, and virus protections; and managed network service. As of December 31, 2020, it operated 32 self-built data centers housing 49,876 cabinets and 52 partnered data centers housing with 3,677 cabinets. It has a strategic partnership with Microsoft Corporation. 21Vianet Group, Inc. was founded in 1999 and is headquartered in Beijing, the People's Republic of China.

NASDAQ ended the session with 21Vianet Group dropping 9.72% to $1.62 on Wednesday, after four sequential sessions in a row of losses. NASDAQ jumped 0.51% to $16,399.52, after two consecutive sessions in a row of losses, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, 21Vianet Group has a trailing twelve months EPS of $-0.25.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.32%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is a negative 200% and a negative 116.7%, respectively.

Earnings Before Interest, Taxes, Depreciation, and Amortization

21Vianet Group’s EBITDA is 4.39.

More news about 21Vianet Group.

5. Celsius Holdings (CELH) – -8.54%

Celsius Holdings, Inc. develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products. It distributes its products through direct-to-store delivery, distributors, supermarkets, convenience stores, drug stores, nutritional stores, and mass merchants, as well as health clubs, gyms, the military, and e-commerce websites. The company was formerly known as Vector Ventures, Inc. and changed its name to Celsius Holdings, Inc. in January 2007. Celsius Holdings, Inc. was founded in 2004 and is headquartered in Boca Raton, Florida.

NASDAQ ended the session with Celsius Holdings sliding 8.54% to $83.43 on Wednesday while NASDAQ rose 0.51% to $16,399.52.

Earnings Per Share

As for profitability, Celsius Holdings has a trailing twelve months EPS of $0.77.

PE Ratio

Celsius Holdings has a trailing twelve months price to earnings ratio of 108.35. Meaning, the purchaser of the share is investing $108.35 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.23%.

More news about Celsius Holdings.

6. DraftKings (DKNG) – -6.84%

DraftKings Inc. operates as a digital sports entertainment and gaming company in the United States and internationally. It provides online sports betting and casino, daily fantasy sports, media, and other consumer products, as well as retails sportsbooks. The company also engages in the design and development of sports betting and casino gaming software for online and retail sportsbooks, and iGaming operators. In addition, it offers DraftKings marketplace, a digital collectibles ecosystem designed for mainstream accessibility that offers curated NFT drops and supports secondary-market transactions. The company is headquartered in Boston, Massachusetts.

NASDAQ ended the session with DraftKings falling 6.84% to $45.35 on Wednesday while NASDAQ jumped 0.51% to $16,399.52.

Earnings Per Share

As for profitability, DraftKings has a trailing twelve months EPS of $-1.73.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -74.17%.

More news about DraftKings.

7. Streamline Health Solutions (STRM) – -6.11%

Streamline Health Solutions, Inc. provides health information technology solutions and associated services for hospitals and health systems in the United States and Canada. It provides computer software-based solutions and auditing services, which captures, aggregates, and translates structured and unstructured data to deliver predictive insights. The company also offers coding and clinical documentation improvement (CDI) solutions, which includes integrated cloud-based software suite, CDI, and abstracting and physician query; and eValuator, a cloud-based pre-bill coding analysis platform. In addition, it provides financial management solutions, including accounts receivable management, denials management, claims processing, spend management, and audit management; patient care solutions; and custom integration services for CDI/abstracting, training, and audit services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions, Inc. was incorporated in 1989 and is based in Alpharetta, Georgia.

NASDAQ ended the session with Streamline Health Solutions falling 6.11% to $0.46 on Wednesday, after five sequential sessions in a row of losses. NASDAQ rose 0.51% to $16,399.52, after two successive sessions in a row of losses, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Streamline Health Solutions has a trailing twelve months EPS of $-0.35.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -72.37%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Streamline Health Solutions’s stock is considered to be overbought (>=80).

Moving Average

Streamline Health Solutions’s worth is under its 50-day moving average of $0.46 and way under its 200-day moving average of $0.74.

Sales Growth

Streamline Health Solutions’s sales growth is negative 18.6% for the current quarter and negative 17.7% for the next.

Yearly Top and Bottom Value

Streamline Health Solutions’s stock is valued at $0.46 at 17:32 EST, way below its 52-week high of $1.90 and way higher than its 52-week low of $0.21.

More news about Streamline Health Solutions.

8. Synergetics USA (SURG) – -5.85%

SurgePays, Inc., through its subsidiaries, provides telecommunication services in the United States. It offers discounted and free wireless services for federal programs, such as SNAP (EBT) and Medicaid; subsidized wireless service to qualifying low income customers; repaid wireless plans with talk, text, and 4G LTE data; and client acquisition and retention services for attorneys and law firms by operating digital marketing campaigns. The company also provides financial technology tech and wireless top-up platform; and SurgePays Blockchain software, an e-commerce platform, which offer wholesale goods and services direct to convenience stores, bodegas, minimarts, tiendas, and other corner stores. In addition, it provides sales support, customer, IT infrastructure design, graphic media, database programming, software development, revenue assurance, lead generation, call center support, and other services. The company was formerly known as Surge Holdings, Inc. and changed its name to SurgePays, Inc. in November 2020. SurgePays, Inc. is headquartered in Bartlett, Tennessee.

NASDAQ ended the session with Synergetics USA sliding 5.85% to $3.86 on Wednesday, after two successive sessions in a row of losses. NASDAQ rose 0.51% to $16,399.52, after two consecutive sessions in a row of losses, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Synergetics USA has a trailing twelve months EPS of $1.3.

PE Ratio

Synergetics USA has a trailing twelve months price to earnings ratio of 2.97. Meaning, the purchaser of the share is investing $2.97 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 123.17%.

More news about Synergetics USA.

9. Translate Bio (TBIO) – -5.19%

Translate Bio, Inc., a clinical-stage messenger RNA (mRNA) therapeutics company, develops medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, which is in Phase I/II clinical trial for the treatment of cystic fibrosis. It is also developing MRT5500 for the treatment of SARS-CoV-2. The company was formerly known as RaNA Therapeutics, Inc. and changed its name to Translate Bio, Inc. in June 2017. Translate Bio, Inc. has a collaboration and license agreement with Sanofi Pasteur Inc. The company was founded in 2011 and is headquartered in Lexington, Massachusetts.

NASDAQ ended the session with Translate Bio dropping 5.19% to $0.44 on Wednesday while NASDAQ rose 0.51% to $16,399.52.

Earnings Per Share

As for profitability, Translate Bio has a trailing twelve months EPS of $-1.31.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -76.49%.

Volume

Today’s last reported volume for Translate Bio is 54373 which is 93.09% below its average volume of 787796.

Yearly Top and Bottom Value

Translate Bio’s stock is valued at $0.44 at 17:32 EST, way under its 52-week high of $3.32 and way higher than its 52-week low of $0.30.

Sales Growth

Translate Bio’s sales growth is negative 26.1% for the ongoing quarter and 10.8% for the next.

Revenue Growth

Year-on-year quarterly revenue growth declined by 16.6%, now sitting on 30M for the twelve trailing months.

More news about Translate Bio.

10. Trinity Biotech plc (TRIB) – -5.16%

Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the United States, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also develops, manufactures, and distributes products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. In addition, the company sells raw materials to the life sciences industry and research institutes. The company sells its products through its direct sales force; and a network of independent distributors and strategic partners. Its customers include public health facilities, hospitals, and other outreach facilities, as well as clinical and reference laboratories. Trinity Biotech plc was founded in 1992 and is headquartered in Bray, Ireland.

NASDAQ ended the session with Trinity Biotech plc falling 5.16% to $2.02 on Wednesday, after four consecutive sessions in a row of losses. NASDAQ rose 0.51% to $16,399.52, after two consecutive sessions in a row of losses, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Trinity Biotech plc has a trailing twelve months EPS of $-4.96.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Trinity Biotech plc’s EBITDA is -55.08.

More news about Trinity Biotech plc.

Stay up to date with our winners and losers daily report

Leave a Reply

Your email address will not be published. Required fields are marked *